Weather Alert
Snow is in the forecast. Consider switching to a virtual visit to receive care from home. Learn more
Popular Search Terms
Barbara Degar, MD
Medical Director, Inpatient Oncology; Attending Physician, Dana-Farber/Boston Children's Cancer and Blood Disorders Center
Assistant Professor in Pediatrics, Harvard Medical School
Image
Barbara Degar, MD
Medical Director, Inpatient Oncology; Attending Physician, Dana-Farber/Boston Children's Cancer and Blood Disorders Center
Assistant Professor in Pediatrics, Harvard Medical School
Medical Services
Languages
English
Education
Undergraduate School
Smith College
1985
Northhampton
MA
Medical School
New York University School of Medicine
1991
New York
NY
Certifications
American Board of Pediatrics (General)
American Board of Pediatrics (Hematology-Oncology)
Publications
Clinical Characteristics and Treatment of Histiocytic Disorders in Children. View Abstract
Histiocytic Disorders in Pediatric and Adult Patients. View Abstract
Over 4 decades, French children teach about LCH. View Abstract
Pharmacogenomic Score Effectively Personalizes Treatment of Acute Myeloid Leukemia. View Abstract
Acute Promyelocytic Leukemia With Torque Teno Mini Virus::RARA Fusion: An Approach to Screening and Diagnosis. View Abstract
Pharmacogenomics, Race, and Treatment Outcome in Pediatric Acute Myeloid Leukemia. View Abstract
Langerhans cell histiocytosis: NACHO update on progress, chaos, and opportunity on the path to rational cures. View Abstract
Disseminated juvenile xanthogranulomas with underlying neurotrophic tyrosine receptor kinase fusion and response to larotrectinib. View Abstract
Acute infusion-related reactions in pediatric patients receiving etoposide at a tertiary cancer center. View Abstract
Dr. Degar et al reply. View Abstract
Hemophagocytic lymphohistiocytosis as an etiology of bone marrow failure. View Abstract
The added value of skeletal surveys in the initial evaluation of children diagnosed with Langerhans cell histiocytosis in the era of staging 18 F-FDG PET/CT: A retrospective study. View Abstract
An Evidence-Based Guideline Improves Outcomes for Patients With Hemophagocytic Lymphohistiocytosis and Macrophage Activation Syndrome. View Abstract
HLH treatment: smarter, not harder. View Abstract
Rapid next-generation sequencing aids in diagnosis of transient abnormal myelopoiesis in a phenotypically normal newborn. View Abstract
Emapalumab in Children with Primary Hemophagocytic Lymphohistiocytosis. View Abstract
Pediatric leukemia cutis: A case series. View Abstract
Clofarabine Can Replace Anthracyclines and Etoposide in Remission Induction Therapy for Childhood Acute Myeloid Leukemia: The AML08 Multicenter, Randomized Phase III Trial. View Abstract
Pediatric CNS-isolated hemophagocytic lymphohistiocytosis. View Abstract
A phase II clinical trial of adoptive transfer of haploidentical natural killer cells for consolidation therapy of pediatric acute myeloid leukemia. View Abstract
Central nervous system-restricted familial hemophagocytic lymphohistiocytosis responds to hematopoietic cell transplantation. View Abstract
Calm in the midst of cytokine storm: a collaborative approach to the diagnosis and treatment of hemophagocytic lymphohistiocytosis and macrophage activation syndrome. View Abstract
Histopathologic Correlates of Familial Hemophagocytic Lymphohistiocytosis Isolated to the Central Nervous System. View Abstract
Acute lymphoblastic leukemia in a patient with MonoMAC syndrome/GATA2 haploinsufficiency. View Abstract
Imaging Features of Juvenile Xanthogranuloma of the Pediatric Head and Neck. View Abstract
Familial Hemophagocytic Lymphohistiocytosis. View Abstract
Management and Outcome of Patients With Langerhans Cell Histiocytosis and Single-Bone CNS-Risk Lesions: A Multi-Institutional Retrospective Study. View Abstract
Ethnicity, race, and socioeconomic status influence incidence of Langerhans cell histiocytosis. View Abstract
Bone marrow engraftment and associated dermatologic sequelae in a three-yr-old after liver transplantation. View Abstract
Prognostic factors in children with acute myeloid leukaemia and excellent response to remission induction therapy. View Abstract
Medication errors in the home: a multisite study of children with cancer. View Abstract
BRAF V600E-Positive Multisite Langerhans Cell Histiocytosis in a Preterm Neonate. View Abstract
Comparative analysis of different approaches to measure treatment response in acute myeloid leukemia. View Abstract
Recent advances in the understanding of Langerhans cell histiocytosis. View Abstract
Neonatal enteroviral sepsis/meningoencephalitis and hemophagocytic lymphohistiocytosis: diagnostic challenges. View Abstract
Recurrent BRAF mutations in Langerhans cell histiocytosis. View Abstract
Minimal residual disease-directed therapy for childhood acute myeloid leukaemia: results of the AML02 multicentre trial. View Abstract
Langerhans cell histiocytosis: malignancy or inflammatory disorder doing a great job of imitating one? View Abstract
Aggressive Langerhans cell histiocytosis following T-ALL: clonally related neoplasms with persistent expression of constitutively active NOTCH1. View Abstract
Mutations of the hemophagocytic lymphohistiocytosis-associated gene UNC13D in a patient with systemic juvenile idiopathic arthritis. View Abstract
The Histiocytoses View Abstract
Oncology (Section Editor) View Abstract
Childhood Cancer View Abstract
Gastrointestinal tract involvement in Langerhans cell histiocytosis: case report and literature review. View Abstract
Hematopoiesis following disruption of the Pitx2 homeodomain gene. View Abstract
Hemophagocytosis exacerbated by G-CSF/GM-CSF treatment in a patient with myelodysplasia. View Abstract
Molecular diagnostics of malignant disorders. View Abstract
Molecular Diagnostics of Malignant Disorders View Abstract
Molecular Basis of Hematology View Abstract
Molecular Basis of Hematology View Abstract
Introduction to the Lymphoproliferative Disorders View Abstract
The homeodomain gene Pitx2 is expressed in primitive hematopoietic stem/progenitor cells but not in their differentiated progeny. View Abstract
Familial Polycythemia Due to Truncations of the Erythropoietin Receptor View Abstract
13-cis-retinoic acid-induced eosinophilia following autologous bone marrow transplantation for neuroblastoma. View Abstract
Familial erythrocytosis associated with a short deletion in the erythropoietin receptor gene. View Abstract
Chemosensitivity of lymphocytes from patients with B-cell chronic lymphocytic leukemia to chlorambucil, fludarabine, and camptothecin analogs. View Abstract